Search
Descriptor English: Clinical Trials, Phase II as Topic
Descriptor Spanish: Ensayos Clínicos Fase II como Asunto
Descriptor ensayos clínicos en fase II como asunto
Scope note: Trabajos sobre estudios, que generalmente son controlados, para evaluar la efectividad y dosificación (si procede) de medicamentos, dispositivos o técnicas diagnósticas, terapéuticas o preventivas. Estos estudios se realizan en varios cientos de voluntarios, incluyendo un número limitado de pacientes con la enfermedad o trastorno objetivo, y duran aproximadamente dos años. Este concepto incluye los ensayos en fase II efectuados en Estados Unidos y en otros países.
Descriptor Portuguese: Ensaios Clínicos Fase II como Assunto
Descriptor French: Essais cliniques de phase II comme sujet
Entry term(s): Drug Evaluation, FDA Phase 2 as Topic
Drug Evaluation, FDA Phase II as Topic
Evaluation Studies, FDA Phase 2 as Topic
Evaluation Studies, FDA Phase II as Topic
Tree number(s): E05.318.372.250.250.210
N05.715.360.330.250.250.210
N06.850.520.450.250.250.210
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D017322
Scope note: Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
Annotation: for general design, methodology, economics, etc. of phase II clinical trials; a different heading CLINICAL TRIAL, PHASE II is used for reports of a specific phase II clinical trial
Allowable Qualifiers: CL classification
EC economics
ES ethics
HI history
IS instrumentation
LJ legislation & jurisprudence
MT methods
PX psychology
SN statistics & numerical data
ST standards
VE veterinary
Previous Indexing: Clinical Trials (1980-1992)
Drug Evaluation (1980-1992)
Public MeSH Note: 2008; see CLINICAL TRIALS, PHASE II 1993-2007; for DRUG EVALUATION, FDA PHASE II see DRUG EVALUATION 1980-1992; for EVALUATION STUDIES, FDA PHASE II see DRUG EVALUATION 1982-1992
History Note: 2008(1993)
DeCS ID: 30783
Unique ID: D017322
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1993/01/01
Date of Entry: 1992/05/13
Revision Date: 2018/06/29
Clinical Trials, Phase II as Topic - Preferred
Concept UI M0026306
Scope note Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
Preferred term Clinical Trials, Phase II as Topic
Evaluation Studies, FDA Phase II as Topic - Narrower
Concept UI M0026305
Preferred term Evaluation Studies, FDA Phase II as Topic
Entry term(s) Evaluation Studies, FDA Phase 2 as Topic
Drug Evaluation, FDA Phase II as Topic - Narrower
Concept UI M0026304
Preferred term Drug Evaluation, FDA Phase II as Topic
Entry term(s) Drug Evaluation, FDA Phase 2 as Topic



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey